Large Volume Parenteral (LVP) Market – Upcoming Trends and Emerging Growth Factors to 2032

Large Volume Parenteral (LVP) Market

The global Large Volume Parenteral (LVP) market size was USD 9.01 Billion in 2022 and is expected to register a revenue CAGR of 6% over the forecast period, according to the latest report by Reports and Data.

An LVP is a larger-than-100ml unit dosage container that has been terminally sterilized by heat. Parenteral formulations are categorized as small or large based on their volume. Small volume parenteral formulations are 100ml or less and can be administered as a single or multiple dosage, whereas big-volume parenteral preparations are greater than 100ml and designed for single usage.

Diabetes is estimated to affect 422 million people worldwide, up from 108 million in 1980, according to the World Health Organization (WHO). Because older people are more likely to develop chronic illnesses and require hospitalization, the demand for LVPs is increasing.

To download a PDF sample copy of the report, visit @  

Some Key Highlights from the Report

  • The global market for LVP or Large Volume Parenteral products witnessed a notable increase in revenue in 2022, with the LVP bags segment holding the largest share of the market. This was primarily due to the exceptional advantages offered by LVP bags, such as their portability, flexibility, and ease of handling. In locations where medical supplies are scarce, LVP bags have become the preferred choice in emergency situations, thanks to their lightweight and convenient storage features. Additionally, LVP bags are safer to handle and transport compared to LVP bottles, as they are less prone to breakage.
  • The fluid balance injection segment is expected to generate the most revenue during the forecast period. This is owing to a high demand for LVP products for fluid balance maintenance in patients suffering from fluid and electrolyte imbalances, dehydration, or hypovolemia. LVP products such as saline solutions and electrolyte solutions are routinely used for fluid replacement treatment in hospitals and other healthcare institutions. Furthermore, the rising prevalence of chronic kidney diseases and renal failure is expected to drive revenue growth in this segment.
  • During the forecast period, the North American market held the greatest share of revenue in the global LVP market, primarily because of the aging population, the growing incidence of chronic diseases, and an upsurge in procedural demand. Nearly six out of every ten individuals in the United States alone suffer from at least one chronic ailment, while four out of ten experience two or more. Additionally, the American Hospital Association (AHA) has reported that hospitals in the U.S. undertake roughly 36 million procedures every year, further fueling the growth of market revenue in this region.
  • During the forecast period, the Europe market is expected to have the fastest-growing revenue rate in the global LVP market. This is related to the increasing prevalence of chronic illnesses and the aging population. Chronic illnesses, according to the World Health Organization (WHO), account for 77% of Europe’s sickness burden. Furthermore, the European Society of Cardiology (ESC) reports that Cardiovascular Diseases (CVDs) account for 45% of all fatalities in Europe. LVPs are likely to boost market revenue growth in this area since they are utilized to treat chronic diseases and offer parenteral nutrition treatment.

Competitive Landscape:

Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Pfizer Inc., Sandoz International GmbH, Hospira Inc., Otsuka Pharmaceutical Co., Ltd., JW Life Science, and ABBOTT.

Type Outlook (Revenue, USD Billion; 2022 – 2032)

  • LVP Bags
  • LVP Bottles
  • Others

Application Outlook (Revenue, USD Billion; 2022 – 2032)

  • Fluid Balance Injection
  • Nutrition Injection
  • Others

Regional analysis provides insights into key trends and demands in each major country that can affect market growth in the region.

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of APAC)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Takeaways of the Competitive Overview Section:

  • Overview of the company profiles of each market player
  • Industrial chain analysis of each player
  • Revenue share contribution
  • Sales network and distribution channels and net profits and losses of each company
  • Key business growth strategies are undertaken by these players

Request a customized copy of the report @ 

Thank you for reading our report. We also offer customized report as per client requirement. Kindly connect with us to know more about customization plan and our team will offer you the altered report.

Get Explore Latest Research Report by Reports and Data:

Hysteroscope Market @

Hysteroscope Market @

Hysteroscope Market @

Hysteroscope Market @

Hysteroscope Market @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370


Back to top button